Reuss A, Wladimiroff J W, Stewart P A, Niermeijer M F
Department of Obstetrics & Gynecology, University Hospital Dijkzigt, Erasmus University Rotterdam, The Netherlands.
Ultrasound Med Biol. 1990;16(4):355-9. doi: 10.1016/0301-5629(90)90065-k.
In 15 pregnancies at risk of the autosomal recessive type of polycystic kidney disease (ARPKD), there were six recurrences (40%), five of which were diagnosed prenatally between 17 and 26 weeks (mean, 22 weeks). In the remaining affected case, normal kidney size and echogenicity were still present at 30 weeks of gestation. Fetal kidney enlargement and increased echogenicity are the key ultrasonographic signs for the detection of ARPKD. Absent fetal bladder filling and oligohydramnios were only documented in two of the six affected pregnancies. The variability in onset, the intrafamilial variability and the limitations of excluding ARPKD by second trimester ultrasound have to be considered when counselling a couple at risk for this particular disorder.
在15例有常染色体隐性多囊肾病(ARPKD)风险的妊娠中,有6例复发(40%),其中5例在孕17至26周(平均22周)时被产前诊断。在其余受影响的病例中,妊娠30周时肾脏大小和回声仍正常。胎儿肾脏增大和回声增强是检测ARPKD的关键超声征象。仅在6例受影响的妊娠中有2例记录到胎儿膀胱无充盈和羊水过少。在为有这种特殊疾病风险的夫妇提供咨询时,必须考虑发病的变异性、家族内变异性以及孕中期超声排除ARPKD的局限性。